The role of complement and its receptor in the elimination of immune complexes
about
Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genesCharacterization of shark complement factor I gene(s): genomic analysis of a novel shark-specific sequenceIntersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19Bacterial persistence and expression of diseaseComplement in Lupus Nephritis: New PerspectivesC1q-bearing immune complexes induce IL-8 secretion in human umbilical vein endothelial cells (HUVEC) through protein tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms: evidence that the 126 kD phagocytic C1q receptor mediateIn vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzeesInfectious diseases associated with complement deficiencies.Mechanism of Platelet Activation and Hypercoagulability by Antithymocyte Globulins (ATG).Antibodies to the five histones and poly(adenosine diphosphate-ribose) in drug induced lupus: implications for pathogenesis.Selective IgA deficiency associated with glomerulonephritis and oligoarthritis.Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane.B-Cell deficiency predisposes mice to disseminating anaerobic infections: protection by passive antibody transfer.Efficient serum clearance of botulinum neurotoxin achieved using a pool of small antitoxin binding agents.C4 null phenotypes among lupus erythematosus patients are predominantly the result of deletions covering C4 and closely linked 21-hydroxylase A genes.Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia.Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patientsThe complement system: history, pathways, cascade and inhibitors.Presence of IgG anti-gp160/120 antibodies confers higher HIV capture capacity to erythrocytes from HIV-positive individuals.Presence of p24-antigen associated to erythrocyte in HIV-positive individuals even in patients with undetectable plasma viral loadProteomic profiling of heterotopic heart-transplanted rats using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: potential biomarkers and drug targets.Complement and systemic lupus erythematosus.Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection.The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties.Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.A unique recombination event resulting in a C4A*Q0,C4B*Q0 double null haplotype.Mannan-binding lectin and complement C4A in Icelandic multicase families with systemic lupus erythematosusRole of the terminal complement pathway in accelerated autologous anti-glomerular basement membrane nephritis.Mechanisms of clearance of immune complexes from peritubular capillaries in the rat.Circulating HBsAg/IgG complexes in idiopathic chronic glomerulonephritisStimulation of mesangial phagocytes does not influence the removal of established glomerular immune complex deposits.Proteomic identification of alpha-2-HS-glycoprotein as a plasma biomarker of hypopharyngeal squamous cell carcinomaMaternal Anti-Fetal Brain IgG Autoantibodies and Autism Spectrum Disorder: Current Knowledge and its Implications for Potential TherapeuticsStructural differences between the two human complement C4 isotypes affect the humoral immune response.Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk.Complement deficiencies in humans and animals: links to autoimmunity.Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).Influence of serotype of group B streptococci on C3 degradation.
P2860
Q24605119-DE5047AC-62CB-4382-AAF8-A84EBACF459BQ24642533-C195BCCC-5B71-4513-BB06-5B31BDAFB256Q24676040-3D9FAEAB-CB33-4B05-8CEF-35388A280E82Q24683702-F25AC9C0-9ED9-4C66-82FB-4FDD92F9689DQ26740491-2008932D-C1E4-4947-934B-45551BA32316Q28348349-D752BE6C-86D7-405C-AB63-93D7E1CE8547Q30449835-AB6BC012-5465-4ABD-84E9-A13B675A26E8Q30450183-89ECEE44-5FD4-4CB4-AC31-8E2E74DB8D14Q33422771-47AA8F11-32F4-435A-B7FD-2972983B5C60Q33557473-5AA978E9-C0AB-4B31-9A08-F3096762DDEBQ33564295-E5A8D82F-017E-4875-BBF7-87505A8DBB42Q33579508-40F6293D-9FE5-4024-B124-C4F198E3B4A9Q33591666-01338DD6-DF72-41BF-910A-3875A6C7C948Q33613925-2223D0F0-F007-434C-A7D3-FAF74AE49A81Q33676915-42C7E54A-4217-4A68-A573-AE257B861EF7Q34002943-3CD32B8B-BBFF-4380-9DE5-9E5032B6A296Q34260546-FCAF7915-44D0-48D8-8C92-B9D1FDD6604BQ34412336-B4C4FEA7-E68F-4496-BDDC-F70F31E90372Q34438445-8815884C-9BF1-4FFD-B304-EE1492A52729Q34498821-96B35ACF-8D6A-48D0-84B6-937DD6E41BD5Q34683526-6870DBE9-EC02-42A7-8C9D-96C029F38FDAQ34731255-8E0A6FCA-83B0-43F9-84C8-AB2AD0A62E9FQ34991385-C3219E36-540A-4449-98D2-F8EFFD906DD1Q35292620-16AD6A63-6847-4438-BAE1-F1CCAD44D56FQ35406116-6F28C432-7FB6-42F0-BE63-E2336D411673Q35606120-DB695C05-2093-4F15-B3EC-23A1968E74A0Q35638080-8986A3B6-852B-4DA1-8159-82702245709FQ35811430-B69C9EAD-3E54-41AE-88E3-8FA8B8384E69Q35831072-60A147BB-EFF0-4BCB-9EA0-5912FB7516BDQ35948713-434EA389-60FC-4AD1-9B04-5D8A174A71BEQ36029285-74AD65A5-755A-4BE1-B84B-790428243551Q36095133-10EF65D6-28DA-4C39-A5E0-ECE37085F7DEQ36161935-CC470B17-9F4E-4D71-A370-C40AC36ADE38Q36230964-361A8691-76C6-44E3-BAC9-0FB45FA30308Q36300934-2641EB31-CBFA-4385-98D3-CADD03A2DA91Q36402570-A0C8A0F5-F301-4BDE-AFE0-3EA68F54AF81Q36572977-E261EFB0-807A-4B47-9991-0BEC07378B37Q36631918-498908DA-58A2-4A1D-A20D-9687CF3DDEEDQ36645449-F84EA621-E863-4436-A398-28806C427740Q36969922-FD91B7F6-44CD-41BE-B64B-C2F6EAB4197C
P2860
The role of complement and its receptor in the elimination of immune complexes
description
1986 nî lūn-bûn
@nan
1986 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
The role of complement and its receptor in the elimination of immune complexes
@ast
The role of complement and its receptor in the elimination of immune complexes
@en
The role of complement and its receptor in the elimination of immune complexes
@nl
type
label
The role of complement and its receptor in the elimination of immune complexes
@ast
The role of complement and its receptor in the elimination of immune complexes
@en
The role of complement and its receptor in the elimination of immune complexes
@nl
prefLabel
The role of complement and its receptor in the elimination of immune complexes
@ast
The role of complement and its receptor in the elimination of immune complexes
@en
The role of complement and its receptor in the elimination of immune complexes
@nl
P2093
P1476
The role of complement and its receptor in the elimination of immune complexes
@en
P2093
D K Peters
J A Schifferli
P304
P356
10.1056/NEJM198608213150805
P407
P577
1986-08-21T00:00:00Z